Ondansetron compared with dexamethasone and metoclopramide as antiemetics in the chemotherapy of breast cancer with cyclophosphamide, methotrexate, and fluorouracil. [electronic resource]
Producer: 19930419Description: 1081-4 p. digitalISSN:- 0028-4793
- Analysis of Variance
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Breast Neoplasms -- drug therapy
- Cyclophosphamide -- administration & dosage
- Dexamethasone -- administration & dosage
- Drug Therapy, Combination
- Female
- Fluorouracil -- administration & dosage
- Humans
- Methotrexate -- administration & dosage
- Metoclopramide -- administration & dosage
- Middle Aged
- Nausea -- prevention & control
- Ondansetron -- administration & dosage
- Regression Analysis
- Vomiting -- chemically induced
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.